Eloxx Pharmaceuticals Inc. Stock News

WALTHAM, Mass., July 21, 2020 -- Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel.

Every investor in Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) should be aware of the most powerful shareholder groups...

WALTHAM, Mass., July 15, 2020 -- Eloxx Pharmaceuticals, Inc., (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel.

Canaccord Genuity analyst Michelle Gilson reiterated a Buy rating on Stoke Therapeutics (STOK – Research Report) today and set a

The Newtownabbey woman is giving something back with new clothing brand '65 roses'

Xeris Pharmaceuticals reports positive topline data for insulin trial. Eloxx restarts cystic fibrosis study. Adamas Pharmaceuticals reports disappointing data f

Shares of Eloxx Pharmaceuticals (OTCMKTS:ELOX) shot up 15.7% during mid-day trading on Thursday . The stock traded as high as $4.02 and last traded at $3.53, 1,051,386 shares traded hands during mid-d

Eloxx Pharmaceuticals (NASDAQ: ELOX) shares are trading higher on Thursday.The company announced that enrollment in its Phase 2 trial for ELX-02 has resumed in Israel and Europe. It was on pause due t

Looking into the current session, Eloxx Pharmaceuticals Inc. (NASDAQ: ELOX) shares are trading at $3.72, after a 21.97% spike. Moreover, over the past month, the stock spiked by 11.38%, but in the pas

Eloxx Pharmaceuticals, Inc., (ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis and other diseases caused by no

Q1 2020 Eloxx Pharmaceuticals Inc Earnings Call

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Ev

Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Digital Realty Trust, Pilgrims Pride and Terraform Power, on Tuesday. HIGH

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Q1 2020 Earnings Conference Call May 7, 2020 16:30 ET Company Participants Barbara Ryan - Investor Relations Greg Will

At this time, I would like to turn the call over to Barbara Ryan, Eloxx Investor Relations. Welcome and thank you for joining us this afternoon for a review of Eloxx Pharmaceuticals' first quarter 20